Sort   by:  
 Page size 
ProteomicsUrine proteomics in IgA nephropathy
we aimed at developing a urinary biomarker-based algorithm that predicts rapid disease progression in IgAN, thus enabling a personalized risk stratification.
ORGANISM(S): Homo sapiens (Human) 
2022-02-15 | PXD020288 | Pride
Ckd Glomerulonephritis : iga Progression Igan Biomarker Urine proteomics 
UnknownEffects of Single and Double Mutants in Human Glucose-6-Phosphate Dehydrogenase Variants Present in the Mexican Population: Biochemical and Structural Analysis.
Not available
S-EPMC7215812 | biostudies-literature
UnknownAutoimmune Diseases and COVID-19 as Risk Factors for Poor Outcomes: Data on 13,940 Hospitalized Patients from the Spanish Nationwide SEMI-COVID-19 Registry.
Not available
S-EPMC8123043 | biostudies-literature
UnknownPrevalence of frequent premature ventricular contractions and nonsustained ventricular tachycardia in older women screened for atrial fibrillation in the Women's Health Initiative.
Not available
S-EPMC11338634 | biostudies-literature
UnknownPrognostic Factors Associated with Acute Heart Failure in Patients Admitted for COVID-19: Analysis of the SEMI-COVID-19 Registry.
Not available
S-EPMC10380653 | biostudies-literature
UnknownClinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS.
Not available
S-EPMC7387884 | biostudies-literature
UnknownUrine proteomics for prediction of disease progression in patients with IgA nephropathy.
Not available
S-EPMC8719618 | biostudies-literature
UnknownAssociation of kidney fibrosis with urinary peptides: a path towards non-invasive liquid biopsies?
Not available
S-EPMC5717105 | biostudies-literature
UnknownDifferences in clinical features and mortality in very old unvaccinated patients (≥ 80 years) hospitalized with COVID-19 during the first and successive waves from the multicenter SEMI-COVID-19 Registry (Spain).
Not available
S-EPMC9244878 | biostudies-literature
UnknownClinician prescription of lipid-lowering drugs and achievement of treatment goals in patients with newly diagnosed type 2 diabetes mellitus.
Not available
S-EPMC7878159 | biostudies-literature
Sort   by:  
 Page size